{"id":"https://openalex.org/W2018431503","doi":"https://doi.org/10.2217/pgs.13.164","title":"Cost\u2013Effectiveness of Using CYP2C19 Genotype to Guide Selection of Clopidogrel or Ticagrelor in Australia","display_name":"Cost\u2013Effectiveness of Using CYP2C19 Genotype to Guide Selection of Clopidogrel or Ticagrelor in Australia","publication_year":2013,"publication_date":"2013-11-26","ids":{"openalex":"https://openalex.org/W2018431503","doi":"https://doi.org/10.2217/pgs.13.164","mag":"2018431503","pmid":"https://pubmed.ncbi.nlm.nih.gov/24279856"},"language":"en","primary_location":{"id":"doi:10.2217/pgs.13.164","doi":"https://doi.org/10.2217/pgs.13.164","is_oa":false,"landing_page_url":"https://doi.org/10.2217/pgs.13.164","pdf_url":null,"source":{"id":"https://openalex.org/S190377370","display_name":"Pharmacogenomics","issn_l":"1462-2416","issn":["1462-2416","1744-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067594062","display_name":"Michael Joseph Sorich","orcid":"https://orcid.org/0000-0003-1999-866X","observed_orcids":["https://orcid.org/0000-0003-1999-866X"]},"institutions":[{"id":"https://openalex.org/I169541294","display_name":"Flinders University","ror":"https://ror.org/01kpzv902","country_code":"AU","type":"education","lineage":["https://openalex.org/I169541294"]},{"id":"https://openalex.org/I170239107","display_name":"University of South Australia","ror":"https://ror.org/01p93h210","country_code":"AU","type":"education","lineage":["https://openalex.org/I170239107","https://openalex.org/I4405259444"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael J Sorich","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, Australia","School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, Australia","institution_ids":["https://openalex.org/I169541294"]},{"raw_affiliation_string":"School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, Australia","institution_ids":["https://openalex.org/I170239107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028734833","display_name":"John David Horowitz","orcid":"https://orcid.org/0000-0001-6883-0703","observed_orcids":["https://orcid.org/0000-0001-6883-0703"]},"institutions":[{"id":"https://openalex.org/I4210099777","display_name":"Queen Elizabeth Hospital","ror":"https://ror.org/00x362k69","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210099777","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John D Horowitz","raw_affiliation_strings":["Cardiology Unit, Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Unit, Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I4210099777","https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059843348","display_name":"Wassana Sorich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802875205","display_name":"Repatriation General Hospital","ror":"https://ror.org/01dsw4m23","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2802875205"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Wassana Sorich","raw_affiliation_strings":["Pharmacy Department, Repatriation General Hospital, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, Repatriation General Hospital, Adelaide, Australia","institution_ids":["https://openalex.org/I2802875205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052330076","display_name":"Michael David Wiese","orcid":"https://orcid.org/0000-0002-3255-9242","observed_orcids":["https://orcid.org/0000-0002-3255-9242"]},"institutions":[{"id":"https://openalex.org/I170239107","display_name":"University of South Australia","ror":"https://ror.org/01p93h210","country_code":"AU","type":"education","lineage":["https://openalex.org/I170239107","https://openalex.org/I4405259444"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael D Wiese","raw_affiliation_strings":["School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, Australia","institution_ids":["https://openalex.org/I170239107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037547423","display_name":"Brita A. K. Pekarsky","orcid":"https://orcid.org/0000-0001-8147-6286","observed_orcids":["https://orcid.org/0000-0001-8147-6286"]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Brita Pekarsky","raw_affiliation_strings":["Baker IDI Heart & Diabetes Institute, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baker IDI Heart & Diabetes Institute, Adelaide, Australia","institution_ids":["https://openalex.org/I142471025"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013630114","display_name":"Jonathan D. Karnon","orcid":"https://orcid.org/0000-0003-3220-2099","observed_orcids":["https://orcid.org/0000-0003-3220-2099"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jonathan D Karnon","raw_affiliation_strings":["School of Population Health, University of Adelaide, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Population Health, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I5681781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3996,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.89588823,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"14","issue":"16","first_page":"2013","last_page":"2021"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyp2c19-genotyping","display_name":"CYP2C19 genotyping","score":0.9129999876022339},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.9470000267028809},{"id":"https://openalex.org/keywords/ticagrelor","display_name":"ticagrelor","score":1.0},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9350000023841858},{"id":"https://openalex.org/keywords/loss-of-function-alleles","display_name":"loss-of-function alleles","score":0.8690000176429749},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9390000104904175},{"id":"https://openalex.org/keywords/coronary-stenting","display_name":"coronary stenting","score":0.9419999718666077},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8539999723434448},{"id":"https://openalex.org/keywords/australia","display_name":"Australia","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.9468778967857361},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.847271203994751},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.8429754972457886},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.5893016457557678},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.471076637506485},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43346336483955383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36456501483917236},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2252281904220581},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.22504186630249023},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.17379015684127808},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12136179208755493},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.05544808506965637},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077144","descriptor_name":"Clopidogrel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077486","descriptor_name":"Ticagrelor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013988","descriptor_name":"Ticlopidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013988","descriptor_name":"Ticlopidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2217/pgs.13.164","doi":"https://doi.org/10.2217/pgs.13.164","is_oa":false,"landing_page_url":"https://doi.org/10.2217/pgs.13.164","pdf_url":null,"source":{"id":"https://openalex.org/S190377370","display_name":"Pharmacogenomics","issn_l":"1462-2416","issn":["1462-2416","1744-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"journal-article"},{"id":"pmid:24279856","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24279856","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"Journal Article"},{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/82689","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2440/82689","pdf_url":null,"source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://dx.doi.org/10.2217/pgs.13.164","raw_type":"Journal article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1553345686","https://openalex.org/W1709234658","https://openalex.org/W1985059672","https://openalex.org/W1989829063","https://openalex.org/W1990283992","https://openalex.org/W1991494494","https://openalex.org/W1993518253","https://openalex.org/W2001370404","https://openalex.org/W2007182242","https://openalex.org/W2007523239","https://openalex.org/W2017468832","https://openalex.org/W2038737814","https://openalex.org/W2056770717","https://openalex.org/W2059223058","https://openalex.org/W2069744613","https://openalex.org/W2074634974","https://openalex.org/W2093138510","https://openalex.org/W2100832086","https://openalex.org/W2119186881","https://openalex.org/W2119377192","https://openalex.org/W2128228188","https://openalex.org/W2140255896","https://openalex.org/W2140501627","https://openalex.org/W2144206796","https://openalex.org/W2150740314","https://openalex.org/W2164340067","https://openalex.org/W2164386459","https://openalex.org/W2169387542","https://openalex.org/W2514160225","https://openalex.org/W2959409865","https://openalex.org/W3037787715"],"related_works":["https://openalex.org/W3128700929","https://openalex.org/W2580858561","https://openalex.org/W3044616731","https://openalex.org/W4417480990","https://openalex.org/W1833889215","https://openalex.org/W2344777885","https://openalex.org/W3026354761","https://openalex.org/W3124590188","https://openalex.org/W2739719611","https://openalex.org/W1997720917"],"abstract_inverted_index":{"AIMS:":[0],"This":[1],"study":[2],"aims":[3],"to":[4,16,32,150],"assess":[5],"the":[6,93,97,125,131,136],"cost-effectiveness":[7,133],"in":[8,106],"Australia":[9],"of":[10,19,53,87,96,117,122],"screening":[11],"CYP2C19":[12,50,103,159],"loss-of-function":[13],"(LoF)":[14],"alleles":[15],"guide":[17],"selection":[18],"clopidogrel":[20,43,62],"or":[21],"ticagrelor":[22,46,54,123],"for":[23,55,63,75,154],"individuals":[24,56,64,155],"with":[25,51,57,114,135],"acute":[26],"coronary":[27,34],"syndrome":[28],"who":[29],"are":[30],"likely":[31,149],"undergo":[33],"stenting.":[35],"METHODS:":[36],"Three":[37],"treatment":[38,77],"strategies":[39],"were":[40,79,89],"compared:":[41],"universal":[42,45,115,120],"therapy,":[44],"therapy":[47],"and":[48,61,71,109,130],"genotyping":[49,104,137],"use":[52,116,121],"a":[58,66,82,158],"LoF":[59,67,160],"allele":[60],"without":[65],"allele.":[68,161],"Lifetime":[69],"costs":[70],"quality-adjusted":[72],"life":[73],"years":[74],"each":[76],"strategy":[78,128,138],"estimated":[80],"using":[81],"Markov":[83],"model.":[84],"The":[85],"risks":[86],"events":[88],"primarily":[90],"derived":[91],"from":[92],"genetic":[94],"substudy":[95],"pivotal":[98],"randomized":[99],"controlled":[100],"trial.":[101],"RESULTS:":[102],"resulted":[105],"greater":[107],"effectiveness":[108],"was":[110,124,139],"cost-effective":[111,152],"when":[112],"compared":[113,134],"clopidogrel.":[118],"However,":[119],"most":[126],"effective":[127],"overall":[129],"incremental":[132],"generally":[140],"within":[141],"what":[142],"is":[143,148],"considered":[144],"acceptable.":[145],"CONCLUSION:":[146],"Ticagrelor":[147],"be":[151],"even":[153],"not":[156],"carrying":[157]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}